Chapters

Transcript

Video

NSCLC Study Presented by Julia Rotow, MD.

Name: NSCLC Study Presented by Julia Rotow, MD.
Uploaded: 2025-06-11T00:00:00+00:00
Description: Dr. Julia Rotow presented results from a study using a cell-free DNA (cfDNA)-guided strategy to personalize first-line treatment for advanced non-small cell lung cancer.

Dr. Julia Rotow presented results from a study using a cell-free DNA (cfDNA)-guided strategy to personalize first-line treatment for advanced non-small cell lung cancer.

Published

June 11, 2025

Created by

Related Presenters

Julia Rotow, MD

Medical Oncology

View full profile

Related Videos

Video

Stereotactic Radiation Presented by Ayal Aizer, MD.

Dr. Ayal Aizer of Dana-Farber Brigham Cancer Center presents results at #ASCO25 from a phase 3 trial on stereotactic radiation.

Video

ReACT 1.0 Study Presented by Glenn Hanna, MD.

Dr. Glenn Hanna presented phase 2 data suggesting that circulating HPV DNA could serve as a real-time biomarker to guide treatment intensity in HPV-positive oropharyngeal cancer.

Video

Talazoparib + Tazemetostat Presented by Atish Choudhury, MD, PhD.

Dr. Atish Choudhury presented clinical trial results evaluating the combination of talazoparib and tazemetostat in advanced prostate cancer.

Video

Phase 2 PROSPECT Study Presented by Lakshmi Nayak, MD.

Lakshmi Nayak, MD presented results from a phase 2 PROSPECT study focused on tirabrutinib and it's effect on patients with relapsed or refractory primary central nervous system lymphoma.

Video

DESTINY-Breast09 Presented by Sara Tolaney, MD, MPH.

Dr. Sara Tolaney of Dana-Farber shares pivotal results from the DESTINY-Breast09 phase 3 trial.

Video

Letrozole + Abemaciclib + Metformin Study Presented by Panos Konstantinopoulos, MD, PhD.

Dr. Panos Konstantinopoulos presented the first study of a triplet therapy combining letrozole, abemaciclib, and metformin in any cancer type.

Video

PRISM-AC Study Presented by Abby Rosenberg, MD, MS.

A new psychosocial intervention is showing promising results for adolescents and young adults (AYA) facing advanced cancer.

Video

TRADE Study Presented by Erica Mayer, MD.

Dr. Erica Mayer shares results from the TRADE study showing a successful abemaciclib dose escalation strategy in patients with HR+ breast cancer.

Video

Colon Cancer Study Presented by Sara Char, MD.

A new study shows that consuming an anti-inflammatory diet could extend overall survival after treatment for stage 3 colon cancer.